Znanstveni rad - Pismo
Postvaccination anaphylaxis and mRNA‐based SARS‐CoV‐2 vaccines — Much ado about nothing?
British Journal of Clinical Pharmacology, 87 (2021), 9; 3632-3633. https://doi.org/10.1111/bcp.14763

Marčec, Robert; Likić, Robert

Citirajte ovaj rad

Marčec, R. i Likić, R. (2021). Postvaccination anaphylaxis and mRNA‐based SARS‐CoV‐2 vaccines — Much ado about nothing?. British Journal of Clinical Pharmacology, 87. (9), 3632-3633. doi: 10.1111/bcp.14763

Marčec, Robert i Robert Likić. "Postvaccination anaphylaxis and mRNA‐based SARS‐CoV‐2 vaccines — Much ado about nothing?." British Journal of Clinical Pharmacology, vol. 87, br. 9, 2021, str. 3632-3633. https://doi.org/10.1111/bcp.14763

Marčec, Robert i Robert Likić. "Postvaccination anaphylaxis and mRNA‐based SARS‐CoV‐2 vaccines — Much ado about nothing?." British Journal of Clinical Pharmacology 87, br. 9 (2021): 3632-3633. https://doi.org/10.1111/bcp.14763

Marčec, R. i Likić, R. (2021) 'Postvaccination anaphylaxis and mRNA‐based SARS‐CoV‐2 vaccines — Much ado about nothing?', British Journal of Clinical Pharmacology, 87(9), str. 3632-3633. doi: 10.1111/bcp.14763

Marčec R, Likić R. Postvaccination anaphylaxis and mRNA‐based SARS‐CoV‐2 vaccines — Much ado about nothing?. British Journal of Clinical Pharmacology [Internet]. 09.2021. [pristupljeno 28.03.2024.];87(9):3632-3633. doi: 10.1111/bcp.14763

R. Marčec i R. Likić, "Postvaccination anaphylaxis and mRNA‐based SARS‐CoV‐2 vaccines — Much ado about nothing?", British Journal of Clinical Pharmacology, vol. 87, br. 9, str. 3632-3633, Rujan 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:451910. [Citirano: 28.03.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.